M&A Deal Summary

Wallaby Medical Acquires phenox

On April 21, 2022, Wallaby Medical acquired medical products company phenox from SHS Capital for 500M EUR

Acquisition Highlights
  • This is Wallaby Medical’s 1st transaction in the Medical Products sector.
  • This is Wallaby Medical’s 0th largest (disclosed) transaction.
  • This is Wallaby Medical’s 1st transaction in Germany.

M&A Deal Summary
Date 2022-04-21
Target phenox
Sector Medical Products
Buyer(s) Wallaby Medical
Sellers(s) SHS Capital
Deal Type Add-on Acquisition
Deal Value 500M EUR

Target

phenox

Bochum, Germany
phenox is a provider of neurovascular products. phenox's portfolio of products trans-catheter-based neurovascular interventions (treatment of ischemic as well as hemorrhagic stroke patients). The comprehensive product range (stent retriever, flow diverter, aspiration catheter, access, coil, balloon, etc.) is sold worldwide. phenox was founded in 2005 and is based in Bochum, Germany.

Search 201,893 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Wallaby Medical

Laguna Hills, California, United States
Category Company
Founded 2015
Sector Medical Products
Employees250
DESCRIPTION

Wallaby Medical is a medical technology company focused on developing and commercializing neurovascular interventional products for treating stroke. Wallaby's product portfolio includes the Avenir® Coil System, a technically differentiated neuro embolic coil system for treating intracranial aneurysms and other neurovascular abnormalities, the Esperance™ Aspiration Catheter, cleared in the U.S. and China for ischemic stroke treatment procedures, and the Esperance™ Distal Access Catheter, which was approved for delivery assistance in China. Wallaby Medical was founded in 2015 and is based in Laguna Hills, California.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Germany) 1 of 1
Year (2022) 1 of 1

Seller(S) 1

SELLER

SHS Capital

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1993
Size Small
Type Sector Focused
DESCRIPTION

SHS Capital is a private equity firm focused on the healthcare sector. Specific areas of interest include life science, medical technology, diagnostics, applied technologies, digital health, and industrial biotechnology. The Firm will consider opportunities at all company stages and looks to commit up to €50 million in businesses valued up to €150 million. Target geographies include Germany, Austria, Switzerland, Scandinavia, and Benelux. SHS Capital was established in 1993 and is headquartered in Tubingen, Germany.

DEAL STATS #
Overall 12 of 17
Sector (Medical Products) 3 of 6
Type (Add-on Acquisition) 7 of 10
Country (Germany) 9 of 13
Year (2022) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-02-15 c-LEcta

Leipzig, Germany

c-LEcta is a developer of enzymes and microbial strains for industrial biotech applications in food, feed, pharma, and chemistry; a self-developed technology platform for the development of new enzymes. c-LEcta was founded in 2004 and is based in Leipzig, Germany.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-22 Dr.Dropin

Oslo, Norway

Dr.Dropin is a healthcare provider that offers general practitioners, specialists, physiotherapists and psychologists at fixed prices with short waiting times. The company has 25 clinics in all major Norwegian cities and also offers most of its services via secure digital solutions. Dr.Dropin was founded in 2017 and is based in Oslo, Norway.

Buy -
Mergr

Product

Company

Legal